Maky Zanganeh, Director at Pulse Biosciences, Inc. (PLSE), bought 21,480 shares at $22.71 ($499K) on 2017-03-20, disclosed to the SEC on 2017-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 8,960 | $215K | 43.1% |
| 2 | $22.47 | 5,000 | $112K | 22.5% |
| 3 | $22.71 | 3,240 | $74K | 14.7% |
| 4 | $22.71 | 3,240 | $74K | 14.7% |
| 5 | $23.78 | 1,040 | $25K | 5.0% |
| Total | $23.24 avg | 21,480 |
| $499K |
| 100% |
| Filing → |
| PLSE | BUY | 2020-06-25 | $13K | — | Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |